8-K: Selectis Health Extends Note Maturity, Appoints New Directors

Selectis Health, Inc. has modified its 2018 Senior Secured Promissory Notes, extending the maturity date to February 28, 2026, increasing the interest rate to 13%, and appointing two new board members.

Summary

• The company entered into a Third Amended and Restated Allonge and Modification Agreement with holders of its 2018 11% Senior Secured Promissory Notes.
• An aggregate principal amount of $1,775,000 in Notes is outstanding as of the effective date.
• The Maturity Date of the Notes is extended to the earlier of February 28, 2026, or the consummation of a Qualified Transaction.
• The Maturity Date can be further extended in successive 30-day periods up to June 30, 2026, if a specific Lis Pendens Notice is not cancelled, with an extension fee of 0.5% of the principal amount per extension.
• The interest rate on the Notes will accrue at 13% per annum, effective January 1, 2026, until paid in full.
• Monthly payments of interest only are due on or before the first day of each month, commencing January 1, 2026.
• The expiration date of Warrants previously granted to Noteholders is extended to December 31, 2027, with the exercise price remaining at $2.25 per share.
• Kent Lund and Lance Baller will be appointed to the company's Board of Directors, effective January 1, 2026.
• The company will pay a solicitation fee of $9,000 to GVC Capital LLC in connection with the modification agreement.
• The company agrees to hold regular board meetings on the second Wednesday of every month or as otherwise agreed.
• The company will exercise best efforts to call an annual meeting of Shareholders no later than August 14, 2026.

Sentiment

Score: 3

Explanation: The modification provides a short-term reprieve by extending debt maturity, but at the cost of a higher interest rate. The need for repeated modifications and the reliance on asset sales for repayment, along with an unresolved legal issue, suggest significant financial challenges and uncertainty.

Positives

• The maturity date extension provides additional time for the company to manage its debt obligations and pursue a Qualified Transaction.
• The warrant expiration date extension to December 31, 2027, maintains potential future equity upside for warrant holders.
• The appointment of new board members, Kent Lund and Lance Baller, could bring fresh perspectives and expertise to corporate governance.
• The commitment to hold regular board meetings and an annual shareholder meeting by August 2026 indicates an effort towards improved corporate governance and transparency.

Negatives

• The interest rate on the Notes increased from 11% to 13% per annum, which will increase the company's debt servicing costs.
• The necessity of a third modification agreement for the same notes suggests ongoing financial challenges or liquidity constraints.
• The short extension period to February 28, 2026, and the potential for further extensions tied to a Lis Pendens Notice, indicate unresolved legal or operational issues.
• A solicitation fee of $9,000 paid to GVC Capital LLC represents an additional expense for the company.

Risks

• The Lis Pendens Notice filed in the case captioned Abbeville Propco Holdco LLC, et al. v. Global Abbeville Property LLC, et al. (Civil Action File No. 25CV06163) could impact the company's ability to consummate a Qualified Transaction or necessitate further debt extensions.
• Failure to consummate a Qualified Transaction by the extended maturity date (February 28, 2026, or later extensions) could lead to default on the Notes.
• The increased interest expense from 11% to 13% per annum will strain the company's cash flow and profitability.
• The company's reliance on asset sales (Qualified Transaction) to retire debt introduces execution risk and market risk related to property valuations and sales timelines.

Future Outlook

The company's immediate future outlook is focused on retiring the outstanding Notes through a 'Qualified Transaction,' which involves the sale of one or more facilities. The extended maturity date provides a short window for this, with potential for further extensions if a specific legal notice (Lis Pendens) remains unresolved. The company also plans to enhance corporate governance through regular board meetings and an annual shareholder meeting by August 2026.

Management Comments

• "Borrower and Lender acknowledge and agree that the foregoing Recitals are true and correct statements of fact and that as of the date of this Modification."
• "Borrower hereby states that it has the requisite authority to enter into this Modification and hereby indemnifies Lender from any and all claims or losses which Lender may incur as a result of any party lacking the necessary requisite authority to enter into this Modification."
• "The Company will exercise best efforts to call an annual meeting of Shareholders no later the August 14, 2026."

Industry Context

This debt modification reflects a common strategy for companies facing liquidity challenges or needing more time to execute strategic asset sales, particularly in sectors like healthcare or real estate where asset divestitures are used to deleverage. The increase in interest rates on secured notes is consistent with a rising interest rate environment or increased perceived risk by lenders. The appointment of new board members is a standard corporate governance practice, often aimed at strengthening oversight or bringing in specific expertise during transitional periods.

Comparison to Industry Standards

• The 13% interest rate on senior secured promissory notes is relatively high, suggesting a higher risk profile compared to investment-grade corporate debt, which typically carries lower rates (e.g., 3-7% for similar maturities depending on credit rating).
• The necessity of a third modification agreement for the same notes indicates ongoing financial strain, unlike more stable companies that typically refinance debt without frequent, complex modifications.
• The extension of warrants to 2027 with a $2.25 exercise price, while previous warrants had a $5.00 exercise price (though replaced by new warrants at $2.25), suggests a significant decline in perceived equity value or a concession to noteholders.
• The inclusion of a 'Qualified Transaction' clause tied to asset sales for debt retirement is a common feature in distressed debt scenarios, similar to restructurings seen in real estate or healthcare sectors where asset divestitures are used to deleverage.

Management Changes

Corporate Governance

Legal Proceedings

• A Lis Pendens Notice filed in the case captioned Abbeville Propco Holdco LLC, Abbeville Opco Holdco LLC, Sparta Propco Holdco LLC, and Sparta Opco Holdco LLC v. Global Abbeville Property LLC, Dodge NH LLC, Providence HR LLC, Atl/Warr LLC, Global Abbeville LLC, Global Eastman LLC, Selectis Sparta LLC, and Selectis Warrenton LLC, Superior Court of Cobb County, Georgia, Civil Action File No. 25CV06163, which could impact the company's ability to extend the maturity date of its notes.

Stakeholder Impact

• Shareholders: Potential dilution if warrants are exercised, but the extension of debt maturity provides a temporary reprieve from immediate default risk. New board members may influence strategic direction. The commitment to an annual meeting is positive for transparency.
• Noteholders: Receive an increased interest rate (13%) and an extended maturity date, providing more time for repayment. Warrants also extended. However, the underlying risk of the company's financial health remains, evidenced by the need for modifications and the short extension.
• Management: Gains additional time to execute asset sales and manage debt, but faces increased scrutiny from new board members and higher debt servicing costs.

Next Steps

• The company is to make monthly interest-only payments commencing January 1, 2026.
• The company is to pursue a 'Qualified Transaction' (sale of facilities) to generate proceeds for Note retirement.
• The company is to monitor and resolve the Lis Pendens Notice to avoid further maturity date extensions.
• The company is to hold regular board meetings on the second Wednesday of every month or as agreed.
• The company is to exercise best efforts to call an annual meeting of Shareholders no later than August 14, 2026.

Key Dates

Recommendation

The filing reveals a company in ongoing financial distress, evidenced by the need for a third debt modification, a higher interest rate on secured notes, and a short maturity extension contingent on asset sales and resolution of a legal dispute. While the extension provides a temporary reprieve, the increased cost of debt and the underlying operational and legal challenges suggest a deteriorating financial position and significant risk to equity holders. The appointment of new directors, while a governance improvement, does not immediately offset these fundamental concerns.

Keywords

Selectis Health, Promissory Notes, Debt Modification, Maturity Extension, Warrants, Board of Directors, Corporate Governance, SEC 8-K, Senior Secured Notes, Interest Rate Increase, Qualified Transaction, Lis Pendens